News
News
Upcoming Events
Subscribe
Our Company
Our Story
Our Vision
Board of Directors
Alzinova Team
Advisers & Collaborators
R & D
Alzheimer's Disease
Our Programs
Specific Targeting of Toxic Aβ Oligomers
The AβCC Peptide™ Technology
Scientific Presentations
Patients & Families
Alzheimer's Patients
Impact on Society
The Unmet Medical Need
Investors
Overview
Rights Issue 2026
Rights Issue 2026
Prospectus and legal information
Analyses
Press Releases
English
Swedish
Subscribe
Presentations
Board and Management
The Share
Financial Reports
Financial Reports - English
Financial Reports – Swedish
Financial Calendar
Corporate Governance
General Meetings
IR Contact
Rights Issue 2026
Rights Issue 2026
Prospectus and legal information
Contact
Contact
Career
News
News
Upcoming Events
Subscribe
Our Company
Our Story
Our Vision
Board of Directors
Alzinova Team
Advisers & Collaborators
R & D
Alzheimer's Disease
Our Programs
Specific Targeting of Toxic Aβ Oligomers
The AβCC Peptide™ Technology
Scientific Presentations
Patients & Families
Alzheimer's Patients
Impact on Society
The Unmet Medical Need
Investors
Overview
Rights Issue 2026
Rights Issue 2026
Prospectus and legal information
Analyses
Press Releases
English
Swedish
Subscribe
Presentations
Board and Management
The Share
Financial Reports
Financial Reports - English
Financial Reports – Swedish
Financial Calendar
Corporate Governance
General Meetings
IR Contact
Rights Issue 2026
Rights Issue 2026
Prospectus and legal information
Contact
Contact
Career
Home
/
Investors
/
Pressreleaser
Overview
Rights Issue 2026
Rights Issue 2026
Prospectus and legal information
Analyses
Press Releases
English
Swedish
Subscribe
Presentations
Board and Management
The Share
Financial Reports
Financial Reports - English
Financial Reports – Swedish
Financial Calendar
Corporate Governance
General Meetings
IR Contact
Pressreleaser
sv
/investors/press-releases-sv/press
